Baroni et al. found unique and necessary presence of autoantibodies in SSc directed to the PDGFR on fibroblasts [1], while other studies found no difference in PDGFR-binding antibodies between control and SSc groups [5], [6] and/or no agonistic activity at all [4], [5]. Here, PDGFRB is linked to systemic sclerosis.